TriSalus Life Sciences In...

NASDAQ: TLSI · Real-Time Price · USD
4.38
0.50 (12.89%)
At close: Aug 15, 2025, 2:43 PM

TriSalus Life Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-31.17M -27.21M -30.06M -55.46M -54.54M -64.18M -59.23M -46.27M -44.12M -27.76M -27.37M -1.93M -726.31K -2.73M 4.77M 1.77M -98.36K -477.23K
Depreciation & Amortization
877K 919K 998K 829K 816K 759K 692K 436K 451K 307K 398K 609K 438K 432K 157K n/a n/a n/a
Stock-Based Compensation
6.59M 5.97M 5.44M 4.74M 3.62M 2.41M 1.4M 519K 378K 380K 368K 314K 195K 125K 63K n/a n/a n/a
Other Working Capital
3.94M 877K 1.33M 542K -1.32M 1.88M 621K -460K -1.23M -1.77M -3.39M -1.63M -1.9M -1.5M 460.62K n/a n/a n/a
Other Non-Cash Items
-5.61M -8.71M -9.7M -1.77M -8.86M -1.95M -1.98M -3.46M 11.22M 5.79M 819.79K -11.53M -12.92M -11.38M -7.81M -3.77M -1.1M 61.62K
Deferred Income Tax
n/a n/a n/a 11.69M 11.69M 11.54M 8.26M -964K -964K -819K 5.96M 3.49M 3.49M 3.49M n/a n/a n/a n/a
Change in Working Capital
938K -5.44M -7.52M -4.01M -7.52M 806K 610K 24K 4.93M 2.61M 246.65K -2.68M -2.52M -1.84M 1.3M 272K -170.12K -467.84K
Operating Cash Flow
-28.37M -34.48M -40.84M -43.98M -54.8M -50.61M -50.25M -49.71M -28.4M -19.87M -19.95M -12.32M -12.33M -12.12M -1.74M -1.73M -1.37M -883.45K
Capital Expenditures
-880K -1.03M -345K -995K -1.25M -1.22M -1.23M -797K -427K -527K -852K -1.11M -1.05M -925K -526K n/a n/a n/a
Cash Acquisitions
40K 40K n/a n/a n/a n/a n/a -1M -1M -1M -1M -1M -1M -1M -1M n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a -191.01K -425.42K -503.55K -503.55K -312.55K -78.14K n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a -8.48M -8.48M -8.48M 223.89M 232.37M 232.37M 232.37M n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a -328K 7.46M 7.46M 7.39M 8.65M 1.15M 1.23M 1.31M 438K 151K 71K 60K -250M -250M -250M
Investing Cash Flow
-840K -993K -345K -995K -1.94M -1.91M -1.92M -1.49M -89K 21K -304K 28K -259K -339K 60K -250M -250M -250M
Debt Repayment
9.89M 32.27M 22.32M 22.32M 21.27M -1.14M -1.14M -1.24M -170K -149K -128K -1K -1K -1K n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a -20K -20K -8.5M -8.5M -240.85M -240.85M -232.37M -232.37M n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
35.8M 15.09M 15.61M 9.71M 24.76M 25.17M 29.94M 20.26M 5.41M 5.63M 917K 1.44M 1.24M 605K 544K 252.01M 252.01M 252.01M
Financial Cash Flow
39.22M 44.5M 37.94M 34.98M 69.42M 49.83M 54.63M 60.49M 20.44M 14.67M 6.8M 1.44M 1.24M 604K 544K 252.01M 252.01M 252.01M
Net Cash Flow
10.01M 9.03M -3.25M -9.99M 12.68M -2.69M 2.46M 9.29M -8.05M -5.17M -13.45M -10.85M -11.35M -11.86M -1.13M 250.96M 251.32M 251.81M
Free Cash Flow
-29.25M -35.51M -41.19M -44.98M -74.57M -70.35M -70M -69.03M -28.82M -20.39M -20.8M -13.42M -13.39M -13.05M -2.26M -1.73M -1.37M -883.45K